Buy me a coffee · $1
×

Support us with a small donation 💝

Every coffee keeps the site running. Thank you!

GLP-1 Class Drugs Drive Structural Shifts in Corporate Healthcare Benefits

 ·  1 min read

Corporate healthcare costs rose an average of 8.5 percent this fiscal year, with GLP-1 obesity treatments accounting for nearly a quarter of total pharmacy spending increases. Human resource departments are recalibrating coverage criteria to maintain fiscal sustainability.

Formulary Adjustments
Major plan sponsors are introducing strict prior-authorization protocols and lifestyle management mandates before approving coverage. Emerging clinical data showing cardiovascular benefits may, however, force long-term coverage mandates from state regulators.